DRUGS USED IN PERIPHERAL VASCULAR DISEASES.
D003850:Deoxyribonuclease I; D004088:Dihydroergotoxine; D010450:Endopeptidases; D004876:Ergot Alkaloids; D005730:Ganglionic Blockers; D006632:Histamine; D006801:Humans; D009525:Niacin; D009539:Nicotinic Acids; D009566:Nitrates; D009573:Nitrites; D010208:Papaverine; D016491:Peripheral Vascular Diseases; D010643:Phenoxybenzamine; D010653:Phenylbutazone; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D013565:Sympatholytics; D014043:Tolazoline; D014652:Vascular Diseases; D014665:Vasodilator Agents; D014970:Xanthines
D004876:Ergot Alkaloids; D005730:Ganglionic Blockers; D009539:Nicotinic Acids; D009566:Nitrates; D009573:Nitrites; D013565:Sympatholytics; D014665:Vasodilator Agents; D014970:Xanthines; D010643:Phenoxybenzamine; D004088:Dihydroergotoxine; D009525:Niacin; D006632:Histamine; D014043:Tolazoline; D010208:Papaverine; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D010450:Endopeptidases; D013300:Streptokinase; D010653:Phenylbutazone
ERGOT ALKALOIDS, HYDROGENATED; GANGLIONIC BLOCKADERS; HISTAMINE; NICOTINIC ACID; NITRATES; NITRITES; PAPAVERINE; PEPTIDE PEPTIDOHYDROLASES; PHENOXYBENZAMINE; PHENYLBUTAZONE; STREPTODORNASE AND STREPTOKINASE; SYMPATHOLYTICS; TOLAZOLINE; VASCULAR DISEASES; VASODILATOR AGENTS; XANTHINES